Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Department of Neurology, University Hospital Essen, Essen, Germany.
Immunity. 2021 Jan 12;54(1):164-175.e6. doi: 10.1016/j.immuni.2020.12.011. Epub 2020 Dec 23.
Patients suffering from Coronavirus disease 2019 (COVID-19) can develop neurological sequelae, such as headache and neuroinflammatory or cerebrovascular disease. These conditions-termed here as Neuro-COVID-are more frequent in patients with severe COVID-19. To understand the etiology of these neurological sequelae, we utilized single-cell sequencing and examined the immune cell profiles from the cerebrospinal fluid (CSF) of Neuro-COVID patients compared with patients with non-inflammatory and autoimmune neurological diseases or with viral encephalitis. The CSF of Neuro-COVID patients exhibited an expansion of dedifferentiated monocytes and of exhausted CD4 T cells. Neuro-COVID CSF leukocytes featured an enriched interferon signature; however, this was less pronounced than in viral encephalitis. Repertoire analysis revealed broad clonal T cell expansion and curtailed interferon response in severe compared with mild Neuro-COVID patients. Collectively, our findings document the CSF immune compartment in Neuro-COVID patients and suggest compromised antiviral responses in this setting.
患 2019 年冠状病毒病(COVID-19)的患者可能会出现神经系统后遗症,如头痛以及神经炎症或脑血管疾病。这些被称为“神经 COVID”的病症在 COVID-19 重症患者中更为常见。为了了解这些神经系统后遗症的病因,我们利用单细胞测序技术,比较了神经 COVID 患者与非炎症性和自身免疫性神经系统疾病患者或病毒性脑炎患者的脑脊液(CSF)中的免疫细胞图谱。神经 COVID 患者的 CSF 中出现了未分化单核细胞和耗竭的 CD4 T 细胞的扩张。神经 COVID CSF 中的白细胞表现出丰富的干扰素特征;然而,这一特征不如病毒性脑炎明显。受体分析显示,与轻症神经 COVID 患者相比,重症患者的 T 细胞克隆广泛扩张,干扰素反应受到抑制。总的来说,我们的研究结果记录了神经 COVID 患者的 CSF 免疫成分,并表明在这种情况下抗病毒反应受损。